CASTLE ROCK, CO--(Marketwire - July 08, 2008) - AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has appointed Michael R. Merson as a new independent member of its board of directors. This appointment brings the total number of company directors to seven, with five serving independently.
